Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Buy
Price to Earnings Rating
Buy
Analyst Rating
Sell
Wall Street Data Solutions Rating
Neutral
B
Passage Bio, Inc. Common Stock (PASG)
Biological Products, (no Disgnostic Substances)
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR
PHILADELPHIA, PA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
02/28/2020
Market Cap
48,215,554
Shares Outstanding
54,820,000
Weighted SO
54,819,638
Total Employees
N/A
Upcoming Earnings
08/05/2024
Similar Tickers
Beta
1.1980
Last Div
0.0000
Range
0.575-1.79
Chg
0.0006
Avg Vol
206230
Mkt Cap
48215554
Exch
NASDAQ
Country
US
Phone
267 866 0311
DCF Diff
0.8903
DCF
-0.0838
Div Yield
0.0000
P/S
8.1555
EV Multiple
-0.6223
P/FV
0.5317
Div Yield %
0.0000
P/E
-0.6288
PEG
-0.0243
Payout
0.0000
Current Ratio
7.6706
Quick Ratio
7.6706
Cash Ratio
2.0000
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
66.4122
CCC
-66.4122
Gross Margin
0.4227
Op Margin
-13.8884
Pretax Margin
-12.9516
Net Margin
-12.9516
Eff Tax Rate
-0.0330
ROA
-0.6106
ROE
-0.7073
ROCE
-0.7266
NI/EBT
1.0000
EBT/EBIT
0.9326
EBIT/Rev
-13.8884
Debt Ratio
0.2086
D/E
0.2888
LT Debt/Cap
0.1987
Total Debt/Cap
0.2241
Int Coverage
-53.1443
CF/Debt
-2.7052
Equity Multi
1.3847
Rec Turnover
0.0000
Pay Turnover
5.4960
Inv Turnover
0.0000
FA Turnover
0.1979
Asset Turnover
0.0471
OCF/Share
-1.1469
FCF/Share
-1.1472
Cash/Share
1.4878
OCF/Sales
-11.9662
FCF/OCF
1.0002
CF Coverage
-2.7052
ST Coverage
-19.1148
CapEx Coverage
-4161.4118
Div&CapEx Cov
-4161.4118
P/BV
0.5317
P/B
0.5317
P/S
8.1555
P/E
-0.6288
P/FCF
-0.6814
P/OCF
-0.6806
P/CF
-0.6806
PEG
-0.0243
P/S
8.1555
EV Multiple
-0.6223
P/FV
0.5317
DPS
0.0000